These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35098540)

  • 21. Convalescent plasma for COVID-19: Donor demographic factors associated high neutralising antibody titres.
    Mehew J; Johnson R; Roberts D; Griffiths A; Harvala H
    Transfus Med; 2022 Aug; 32(4):327-337. PubMed ID: 35434868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A patient with severe COVID-19 treated with convalescent plasma].
    Hahn M; Condori MEH; Totland A; Kristoffersen EK; Hervig TA
    Tidsskr Nor Laegeforen; 2020 Sep; 140(12):. PubMed ID: 32900176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Convalescent plasma and COVID-19: Time for a second-second look?
    Joyner MJ; Carter RE; Fairweather D; Wright RS
    Transfus Med; 2023 Feb; 33(1):16-20. PubMed ID: 36089562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid recovery of taste and smell in a patient with SARS-CoV-2 following convalescent plasma therapy.
    Fisher DL; Pavel A; Malnick S
    QJM; 2021 Aug; 114(5):319-320. PubMed ID: 33416888
    [No Abstract]   [Full Text] [Related]  

  • 26. Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.
    Casadevall A; Joyner MJ; Pirofski LA
    Clin Infect Dis; 2021 Aug; 73(3):e540-e542. PubMed ID: 32805024
    [No Abstract]   [Full Text] [Related]  

  • 27. "A Most Equitable Drug": How the Clinical Studies of Convalescent Plasma as a Treatment for SARS-CoV-2 Might Usefully Inform Post-Pandemic Public Sector Approaches to Drug Development.
    Grundy Q; Campbell C; Ali R; Herder M; Holloway K
    J Law Med Ethics; 2024; 52(1):80-97. PubMed ID: 38818600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Convalescent plasma for COVID-19 considerations.
    Adiwinata Pawitan J
    Transfus Apher Sci; 2021 Feb; 60(1):102927. PubMed ID: 32878733
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of transfusion convalescent recovery plasma in patients with coronavirus disease 2019.
    Xiao K; Lin Y; Fan Z; Wen Y; Huang H; Wang M; Ren D; Wu C; Liu W; Zhang Z; Li G; LE A
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):565-570. PubMed ID: 32879108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Convalescent plasma for patients with COVID-19.
    Zeng F; Chen X; Deng G
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12528. PubMed ID: 32398379
    [No Abstract]   [Full Text] [Related]  

  • 32. Convalescent plasma to treat COVID-19: clinical experience and efficacy.
    Pei S; Yuan X; Zhang Z; Yao R; Xie Y; Shen M; Li B; Chen X; Yin M
    Aging (Albany NY); 2021 Mar; 13(6):7758-7766. PubMed ID: 33735836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Is convalescent plasma an alternative treatment for Covid-19 patients?].
    Trejo-Gómor JE; Dimas-González J; Lagunas-Martínez A
    Salud Publica Mex; 2020; 62(6):870-871. PubMed ID: 33620985
    [No Abstract]   [Full Text] [Related]  

  • 34. Convalescent plasma for COVID-19 - encouraging signals of efficacy.
    Casadevall A; Tobian AAR
    Br J Haematol; 2021 Feb; 192(4):681-682. PubMed ID: 33524158
    [No Abstract]   [Full Text] [Related]  

  • 35. Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2.
    Taşlı NP; Gönen ZB; Kırbaş OK; Gökdemir NS; Bozkurt BT; Bayrakcı B; Sağraç D; Taşkan E; Demir S; Ekimci Gürcan N; Bayındır Bilgiç M; Bayrak ÖF; Yetişkin H; Kaplan B; Pavel STI; Dinç G; Serhatlı M; Çakırca G; Eken A; Aslan V; Yay M; Karakukcu M; Unal E; Gül F; Basaran KE; Ozkul Y; Şahin F; Jones OY; Tekin Ş; Özdarendeli A; Cetin M
    Front Immunol; 2022; 13():824378. PubMed ID: 35401544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China.
    Huang S; Shen C; Xia C; Huang X; Fu Y; Tian L
    Med Sci Monit; 2020 Dec; 26():e928755. PubMed ID: 33264276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19.
    Nnaji CA; Iwu CJ; Ndwandwe DE; Jordan P; Wiysonge CS
    S Afr Med J; 2020 Jul; 110(8):759-760. PubMed ID: 32880303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.
    Nomoto H; Kutsuna S; Okuma K; Kuramitsu M; Tezuka K; Ikebe E; Saito S; Kinoshita N; Terada M; Endo M; Suzuki T; Miyazato Y; Nakamoto T; Inada M; Hamaguchi I; Ohmagari N
    J Infect Chemother; 2021 Apr; 27(4):653-655. PubMed ID: 33487533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of convalescent plasma in hospitalized patients with COVID-19: case series.
    Hegerova L; Gooley TA; Sweerus KA; Maree C; Bailey N; Bailey M; Dunleavy V; Patel K; Alcorn K; Haley R; Johnsen JM; Konkle BA; Lahti AC; Alexander ML; Goldman JD; Lipke A; Lim SJ; Sullivan MD; Pauk JS; Pagel JM
    Blood; 2020 Aug; 136(6):759-762. PubMed ID: 32559767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Convalescent plasma as a potential therapy for COVID-19.
    Chen L; Xiong J; Bao L; Shi Y
    Lancet Infect Dis; 2020 Apr; 20(4):398-400. PubMed ID: 32113510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.